Waltz Quoted on ROI from Anti-Fraud Efforts Under President Trump
March 20, 2017
Bloomberg BNA
Partner Judy Waltz was quoted in a Bloomberg BNA article, “Trump Budget Would Boost Spending to Fight Medicare, Medicaid Fraud,” covering the ideal return on investment from anti-fraud efforts, and the integrity of the Trump administration’s anti-fraud program as a whole.
Waltz explains that the support for program integrity “is because the [Health Care Fraud and Abuse Control] program has been able to demonstrate a good return on investment, both in actual dollars and in the nonquantifiable deterrent side as well.”
She continues to say that, however, “with the administration’s statements about reducing regulatory burdens, there may be less emphasis on fraud, waste and abuse allegations that reflect regulatory noncompliance [in the future].”
Waltz explains that the support for program integrity “is because the [Health Care Fraud and Abuse Control] program has been able to demonstrate a good return on investment, both in actual dollars and in the nonquantifiable deterrent side as well.”
She continues to say that, however, “with the administration’s statements about reducing regulatory burdens, there may be less emphasis on fraud, waste and abuse allegations that reflect regulatory noncompliance [in the future].”
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.